Table 1.
Weighted prevalence of clinical oral fungal infection by cancer therapy
| Cancer therapy |
Number of studies [references] |
Total number of subjects |
Prevalence pre-treatment: mean (SE) [95% CI] |
Prevalence during treatment mean (SE) [95% CI] |
Prevalence post- treatment mean (SE) [95% CI] |
|---|---|---|---|---|---|
| All treatments | Eleven [3, 33–36, 38–40, 44–46] | 478 | 7.5% | 39.1% (0.08) [21.0–57.2] | 32.6% (0.09) [0–100] |
| CT only | Five [34, 38, 39, 45, 46] | 212 | NA | 38.0% (0.13) [1.2–74.7] | NA |
| RT only | Six [3, 33, 35, 36, 40, 44] | 260 | 7.5% | 37.4% (0.16) [0–88.4] | 32.6% (0.09) [0–100] |
| CT + RT | One [36] | 6 | NA | 66.7%a | NA |
CT chemotherapy, RT radiation therapy, SE standard error, CI confidence interval, NA not available due to lack of eligible papers providing this data
a
There is no SE or CI listed because these data were derived from only one eligible paper